Polen Capital Management
CLBT icon

Polen Capital Management’s Cellebrite CLBT Stock Holding History

Polen Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,849
Closed -$289K – 247
2025
Q1 		$289K Buy
14,849
+4,754
+47% +$100K ﹤0.01% 117
2024
Q4 		$222K Buy
+10,095
New +$194K ﹤0.01% 123

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Polen Capital Management's CLBT Position: Q2 2025 in Review

Polen Capital Management sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 14,849 shares — an estimated $289K sold.

Polen Capital Management first reported a position in CLBT in Q4 2024 and held it in 2 quarters. The position peaked at $289K in Q1 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Polen Capital Management reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Polen Capital Management sold 14,849 Cellebrite shares in Q2 2025, an estimated $289K.
  • Polen Capital Management first reported a position in Cellebrite in Q4 2024 and held it in 2 quarters.
  • Polen Capital Management's Cellebrite position peaked at $289K in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Polen Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.